Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-22

Clinical Trial Update: French National Cohort of Patients With Rifampicin-Resistant Tuberculosis

View source ↗

Summary

A clinical trial update for a French national cohort of patients with rifampicin-resistant tuberculosis; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Rifampicin-resistant Tuberculosis | Status: NOT_YET_RECRUITING